Fifth Lane Capital’s Chemours CC Stock Holding History

Fifth Lane Capital’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,000	Closed	-$118K	–	73
2025 Q4	$118K	Buy	+10,000	New	+$128K	0.09%	90

Other funds holding CC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

WHCM

Wolf Hill Capital Management Greenwich, Connecticut $1.03B AUM 80.44% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fifth Lane Capital's CC Position: Q1 2026 in Review

Fifth Lane Capital sold out of Chemours (CC) in Q1 2026, closing a stake of 10,000 shares — an estimated $118K sold.

Fifth Lane Capital first reported a position in CC in Q4 2025 and held it in 1 quarter. The position peaked at $118K in Q4 2025. 448 funds tracked by Wall St. Rank hold CC as of Q1 2026.

Fifth Lane Capital reported no remaining Chemours position as of Q1 2026 after selling out during the quarter.
Fifth Lane Capital sold 10,000 Chemours shares in Q1 2026, an estimated $118K.
Fifth Lane Capital first reported a position in Chemours in Q4 2025 and held it in 1 quarter.
Fifth Lane Capital's Chemours position peaked at $118K in Q4 2025.
448 funds tracked by Wall St. Rank held Chemours as of Q1 2026.

Based on Fifth Lane Capital's 13F filing for Q1 2026, filed 15 May 2026.